Non-invasive diagnostics of liver fibrosis in patients with type 2 diabetes in daily practice
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F27283933%3A_____%2F18%3A00006565" target="_blank" >RIV/27283933:_____/18:00006565 - isvavai.cz</a>
Výsledek na webu
—
DOI - Digital Object Identifier
—
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Non-invasive diagnostics of liver fibrosis in patients with type 2 diabetes in daily practice
Popis výsledku v původním jazyce
Introduction: The amount of liver fibrosis represents the most impoortant prognostic factor oin NAFLD. We aimed to assess the possibilities of non-invasive staging of liver fibrosis in difficult to examine patients. Methods: 93 consecutive patients with type 2 diabetes(DM2) with late complications were examined (basic laboratory examination, anthropometric parameters, abdominal ultrasound with poin shear wave elastography). Non invasive scores of liver fibrosis (APRI, FIB-4, BARD, NAFLD fibrosis score) were calculated. Results: We examined 93 patients (mean age 68 -10.1 years, BMI 30.1 -4.58, waist circumference 110 -11.1 cm, none patient had normal waist circumference, all had metabolic syndrome). Steatosis was present in 65 (70%) patients, elastography measurement meeting quality criteria was possible in 56 (60%) patients, borderline in 17 (18.2%), not possible in 20 (21.5%) patients. 7 patients (9.6%) reliable borderline measurable group had values in a range of advanced fibrosis/cirrhosis (F3/4). The reliability of measurement was associated with lower BMI, waist circumference and thoracic wall thickness. In the group of patients which couldn`t have been measured the non-invasive scores were of no use, because they brought controversial results. Discussion/Conclusion: Type 2 diabetic patients with late complications represent a subgroup of patient with significant prevalence of advanced liver fibrosis/cirrhosis. In a substantial amount of these patients elastography measurement is unreliable and basic non-invasive scoring systems are of no help.
Název v anglickém jazyce
Non-invasive diagnostics of liver fibrosis in patients with type 2 diabetes in daily practice
Popis výsledku anglicky
Introduction: The amount of liver fibrosis represents the most impoortant prognostic factor oin NAFLD. We aimed to assess the possibilities of non-invasive staging of liver fibrosis in difficult to examine patients. Methods: 93 consecutive patients with type 2 diabetes(DM2) with late complications were examined (basic laboratory examination, anthropometric parameters, abdominal ultrasound with poin shear wave elastography). Non invasive scores of liver fibrosis (APRI, FIB-4, BARD, NAFLD fibrosis score) were calculated. Results: We examined 93 patients (mean age 68 -10.1 years, BMI 30.1 -4.58, waist circumference 110 -11.1 cm, none patient had normal waist circumference, all had metabolic syndrome). Steatosis was present in 65 (70%) patients, elastography measurement meeting quality criteria was possible in 56 (60%) patients, borderline in 17 (18.2%), not possible in 20 (21.5%) patients. 7 patients (9.6%) reliable borderline measurable group had values in a range of advanced fibrosis/cirrhosis (F3/4). The reliability of measurement was associated with lower BMI, waist circumference and thoracic wall thickness. In the group of patients which couldn`t have been measured the non-invasive scores were of no use, because they brought controversial results. Discussion/Conclusion: Type 2 diabetic patients with late complications represent a subgroup of patient with significant prevalence of advanced liver fibrosis/cirrhosis. In a substantial amount of these patients elastography measurement is unreliable and basic non-invasive scoring systems are of no help.
Klasifikace
Druh
O - Ostatní výsledky
CEP obor
—
OECD FORD obor
30219 - Gastroenterology and hepatology
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2018
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů